Perzinfotel
Overview[edit]
Perzinfotel is a chemical compound that has been studied for its potential use as a neuroprotective agent. It is known to act as an NMDA receptor antagonist, which means it can inhibit the action of the N-methyl-D-aspartate receptor, a type of receptor for the neurotransmitter glutamate. This action is thought to be beneficial in conditions where excessive activation of NMDA receptors leads to neuronal damage, such as in stroke or traumatic brain injury.
Mechanism of Action[edit]
Perzinfotel functions by blocking the NMDA receptor, which is a subtype of glutamate receptors. These receptors are involved in synaptic plasticity and memory function. However, overactivation of NMDA receptors can lead to excitotoxicity, a process that results in cell death. By inhibiting these receptors, Perzinfotel may help to protect neurons from damage.
Potential Applications[edit]
Research into Perzinfotel has primarily focused on its potential to treat conditions involving excitotoxicity. These include:
- Stroke: During a stroke, the lack of blood flow to the brain can lead to excessive release of glutamate, causing excitotoxicity.
- Traumatic brain injury: Similar to stroke, brain injuries can result in increased glutamate levels and subsequent neuronal damage.
- Neurodegenerative diseases: Conditions such as Alzheimer's disease and Parkinson's disease may involve excitotoxic mechanisms.
Challenges and Considerations[edit]
While the theoretical benefits of NMDA receptor antagonists like Perzinfotel are significant, there are challenges in their development and use. These include potential side effects such as cognitive impairment and psychotomimetic effects, which are common with NMDA receptor antagonists.
Research and Development[edit]
Research into Perzinfotel is ongoing, with studies focusing on its efficacy and safety profile. Animal models have been used to assess its neuroprotective effects, and further clinical trials are needed to determine its potential therapeutic applications in humans.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian